Author:
Dong Yuesheng,Yang Junshan,Ren Xiao,Zhang Hua,He Jiangong
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference9 articles.
1. Nishikawa M, Tsurumi Y, Namiki T, Yoshida K, Okuhara M . Studies on WF-3681, a novel aldose reductase inhibitor I. Taxonomy, fermentation, isolation and characterization. J Antibiot 40: 1394–1399 ( 1987)
2. Rao KCS, Divakar S, Srinivas M, Babu KN, Karanth NG, Sattur AP . Asperaldin, a new aldose reductase inhibitor from Aspergillus niger CFR-1046. I. Fermentation, isolation and characterization. J Antibiot 56: 173–176 ( 2003)
3. Rao KCS, Divakar S, Babu KN, Rao AGA, Karanth NG, Sattur AP . Nigerloxin, a novel inhibitor of aldose reductase and lipoxygenase with free radical scavenging activity from Aspergillus niger CFR-W-105. J Antibiot 55: 789–793 ( 2002)
4. Dvornik E, Simard-Duquesne N, Krami M, Sestanj K, Gabbay KH, Kinoshita JH, Varma SD, Merola LO . Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science 182: 1146–1148 ( 1973)
5. Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K . Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes. In Vivo 17: 177–180 ( 2003)
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献